Tsumura Toekomstige groei
Future criteriumcontroles 2/6
Tsumura zal naar verwachting groeien in winst en omzet met respectievelijk 7.1% en 8% per jaar. De winst per aandeel zal naar verwachting groeien met 7.1% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 9.3% zijn.
Belangrijke informatie
7.1%
Groei van de winst
7.1%
Groei van de winst per aandeel
Pharmaceuticals winstgroei | 11.7% |
Inkomstengroei | 8.0% |
Toekomstig rendement op eigen vermogen | 9.3% |
Dekking van analisten | Low |
Laatst bijgewerkt | 08 Nov 2024 |
Recente toekomstige groei-updates
Recent updates
Tsumura & Co. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Nov 11Tsumura & Co.'s (TSE:4540) Intrinsic Value Is Potentially 47% Above Its Share Price
Oct 17Tsumura (TSE:4540) Is Increasing Its Dividend To ¥68.00
Sep 26Tsumura & Co.'s (TSE:4540) P/E Still Appears To Be Reasonable
Sep 24Tsumura (TSE:4540) Will Pay A Larger Dividend Than Last Year At ¥68.00
Sep 04Tsumura (TSE:4540) Is Increasing Its Dividend To ¥68.00
Aug 21Tsumura's (TSE:4540) Promising Earnings May Rest On Soft Foundations
Aug 12Tsumura's (TSE:4540) Upcoming Dividend Will Be Larger Than Last Year's
Jul 25Tsumura (TSE:4540) Has Announced That It Will Be Increasing Its Dividend To ¥68.00
Jul 11We Think Tsumura (TSE:4540) Can Stay On Top Of Its Debt
Jun 24News Flash: Analysts Just Made A Sizeable Upgrade To Their Tsumura & Co. (TSE:4540) Forecasts
Mar 28Tsumura (TSE:4540) Will Pay A Dividend Of ¥35.00
Mar 15Earnings Not Telling The Story For Tsumura & Co. (TSE:4540) After Shares Rise 39%
Mar 07Tsumura (TSE:4540) Has Announced A Dividend Of ¥35.00
Feb 26Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
3/31/2027 | 212,532 | 33,764 | 13,549 | 41,206 | 5 |
3/31/2026 | 199,040 | 31,853 | 8,165 | 36,754 | 5 |
3/31/2025 | 185,570 | 30,137 | -5,771 | 28,985 | 5 |
9/30/2024 | 164,614 | 25,204 | 814 | 22,107 | N/A |
6/30/2024 | 157,499 | 23,555 | -14,084 | 4,383 | N/A |
3/31/2024 | 150,845 | 16,707 | -14,449 | 5,608 | N/A |
12/31/2023 | 148,793 | 16,758 | -9,272 | 6,724 | N/A |
9/30/2023 | 145,238 | 13,598 | -8,657 | 7,365 | N/A |
6/30/2023 | 142,662 | 14,182 | -3,937 | 11,515 | N/A |
3/31/2023 | 140,043 | 16,482 | 1,744 | 16,452 | N/A |
12/31/2022 | 138,240 | 19,322 | -1,315 | 12,429 | N/A |
9/30/2022 | 136,237 | 20,760 | 5,818 | 19,187 | N/A |
6/30/2022 | 132,192 | 20,079 | 11,231 | 22,739 | N/A |
3/31/2022 | 129,546 | 18,836 | 10,727 | 21,314 | N/A |
12/31/2021 | 129,783 | 17,365 | 9,873 | 21,242 | N/A |
9/30/2021 | 130,305 | 17,214 | 7,098 | 17,263 | N/A |
6/30/2021 | 130,886 | 16,676 | 2,268 | 14,016 | N/A |
3/31/2021 | 130,883 | 15,332 | 6,686 | 16,102 | N/A |
12/31/2020 | 127,545 | 15,431 | 11,871 | 20,232 | N/A |
9/30/2020 | 126,440 | 14,811 | 11,756 | 20,149 | N/A |
6/30/2020 | 124,317 | 13,907 | 9,671 | 18,742 | N/A |
3/31/2020 | 123,248 | 13,765 | 7,639 | 18,191 | N/A |
12/31/2019 | 124,081 | 14,552 | 3,461 | 13,813 | N/A |
9/30/2019 | 123,440 | 14,548 | 569 | 9,667 | N/A |
6/30/2019 | 121,829 | 14,980 | -4,825 | 5,160 | N/A |
3/31/2019 | 120,906 | 14,593 | -3,491 | 5,450 | N/A |
12/31/2018 | 118,978 | 13,933 | -887 | 8,682 | N/A |
9/30/2018 | 117,865 | 14,972 | 1,544 | 14,132 | N/A |
6/30/2018 | 118,587 | 14,826 | N/A | 17,620 | N/A |
3/31/2018 | 117,879 | 14,504 | N/A | 21,066 | N/A |
12/31/2017 | 117,906 | 13,627 | N/A | 20,388 | N/A |
9/30/2017 | 116,877 | 13,791 | N/A | 18,965 | N/A |
6/30/2017 | 115,330 | 12,730 | N/A | 24,176 | N/A |
3/31/2017 | 114,954 | 12,488 | N/A | 21,065 | N/A |
12/31/2016 | 114,022 | 13,079 | N/A | 21,811 | N/A |
9/30/2016 | 114,424 | 11,330 | N/A | 20,522 | N/A |
6/30/2016 | 114,557 | 12,373 | N/A | 15,468 | N/A |
3/31/2016 | 112,625 | 12,557 | N/A | 17,570 | N/A |
12/31/2015 | 111,986 | 12,550 | N/A | 13,354 | N/A |
9/30/2015 | 112,288 | 14,485 | N/A | 13,662 | N/A |
6/30/2015 | 110,570 | 14,206 | N/A | 10,236 | N/A |
3/31/2015 | 110,438 | 14,075 | N/A | 4,992 | N/A |
12/31/2014 | 112,445 | 15,407 | N/A | 4,799 | N/A |
9/30/2014 | 109,369 | 17,109 | N/A | 5,857 | N/A |
6/30/2014 | 110,187 | 17,248 | N/A | 5,476 | N/A |
3/31/2014 | 110,057 | 18,050 | N/A | 5,908 | N/A |
12/31/2013 | 107,821 | 18,023 | N/A | 11,095 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei 4540 ( 7.1% per jaar) ligt boven de spaarquote ( 0.3% ).
Winst versus markt: De winst van 4540 ( 7.1% per jaar) zal naar verwachting langzamer groeien dan de markt JP ( 7.9% per jaar).
Hoge groeiwinsten: De winst van 4540 zal naar verwachting groeien, maar niet aanzienlijk.
Omzet versus markt: De omzet van 4540 ( 8% per jaar) zal naar verwachting sneller groeien dan de markt JP ( 4.1% per jaar).
Hoge groei-inkomsten: De omzet van 4540 ( 8% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen 4540 zal naar verwachting over 3 jaar laag zijn ( 9.3 %).